Evaluating Cutimed<sup>®&gt;</sup> Sorbact<sup>®&gt;</sup>: using a case study approach

Powell, Gail

doi:10.12968/bjon.2009.18.sup5.43571

Cited by 5 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of these 252, 34 were considered for inclusion after screening by title and abstract, and the full text sought. After full text reading, 17 were considered to be suitable for inclusion [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] (Table 2).…”

Section: Results Of the Search And Included Studiesmentioning

confidence: 99%

Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Results Of the Search And Included Studiesmentioning

confidence: 99%

Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review

et al. 2017

View full text Add to dashboard Cite

show abstract

“…The comparison was done with Cutimed Sorbact as it is already an established commercial bacteria-capturing wound dressing. [45,46] Visual analysis of the agar plates for both E. coli and B. subtilis showed no difference in bacteria infiltration or capture in the presence or absence of bovine serum albumin (BSA) in simulated wound fluid for alumina textiles as well as for Cutimed Sorbact (see Figures S3A,B and S4A,B, Supporting Information). The OD of resuspended bacteria also confirmed this observation (see Figures S3C and S4C, Supporting Information).…”

Section: Bacteria Capture Testsmentioning

confidence: 99%

Alumina Ceramic Textiles as Novel Bacteria‐Capturing Wound Dressings

Dutta,

Almeida,

Karim

et al. 2024

Adv Materials Inter

View full text Add to dashboard Cite

Although antimicrobial dressings have proven to be crucial in the treatment of wounds, they may give rise to antibiotic‐resistant strains or result in the release of endotoxins after bacterial death, which in turn inhibits wound healing. This study highlights the efficacy of a novel alumina ceramic textile as dressing that utilizes the principles of bacteria capture from the wound bed and inhibition of bacterial infiltration into the wound bed to reduce the bacterial burden and to inhibit the spread of infection, without the involvement of active antimicrobial substances or functional nanoparticles. The alumina textiles are compared to commercial dressings like the non‐woven mesh Cutimed Sorbact and gauzes from LEINA WERKE and performed significantly better in capturing bacteria. They are found to be effective against both Gram‐negative Escherichia coli and Gram‐positive Bacillus subtilis and show promising results in the presence of simulated wound fluid and in artificial wound bed tests from which they can be easily lifted without leaving behind any visible residues. In summary, the alumina textiles exhibit a highly efficient bacterial binding activity, possibly due to the intrinsic material properties of their hierarchical structure including the tricot knit mesh, small fiber diameters, pronounced fiber surface microtopography, and high specific surface area.

show abstract

“…Cutimed Sorbact dressings remove bacteria through hydrophobic interactions. They are coated with a fatty acid derivative that attracts bacteria to the dressing, where they are bound [68].…”

Section: Skin Genetic Disorders: Epidermolysis Bullosamentioning

confidence: 99%

Enhancing Skin Cicatrization with Natural Sources – The Role of Polyunsaturated Fatty Acids (PUFAs) and Beeswax

Saretzky¹,

Cassini²

2023

Cosmetic Products and Industry - New Advances and Applications

View full text Add to dashboard Cite

Objectives: To evaluate the effectiveness and tolerance in patients with RDEB of an ointment with the following active ingredients: petroleum jelly (30%), cod liver oil (10%), beeswax, sunflower oil, BHT, sweet almond oil. The formulation does not contain antibiotics or corticosteroids. Methods: A prospective study was carried out on a cohort of ten patients diagnosed with RDEB confirmed by molecular biology that are followed at the Centre for Research in Genodermatosis and EB. Given the seriousness of the pathology and the difficulties in obtaining good results with the therapeutic resources available, a one-year pilot test was performed with the use of an off-label drug. The therapeutic effectiveness was evaluated as well as the tolerance and safety of the ointment. Patients with infected injuries, anaemic with hemoglobin levels lower than 8 g/dl or albumin levels lower than 3 g/dl were excluded from the study. Before starting the treatment, a complete blood test was carried out. Lesions were evaluated by a grading system considering the compromise, depth and edges of the injury. Photographs of the injuries were taken at the beginning and at weekly controls for the first month and later monthly. The ointment was applied after bathing on sterilised dressings, followed by the placement of secondary dressings that allowed the oxygenation of the lesions. Both applications were changed every 12 or 24 hours. Results: The drug was evaluated for the period of one-year in each patient. No adverse effects were observed. It was well tolerated and blood tests results were not affected. After 48 hours of initiating the treatment the patients reported: absence of pain, increase of average sleep, decrease in the use of analgesic medication, faster healing of blisters in the skin, diminishing the affected areas and significant improvement in life quality. Conclusions: Even though the number of patients in the study was small, the results obtained allow us to conclude that this medication may be beneficial to alleviate the signs and symptoms of patients with RDEB. Subsequent studies on a greater number of patients will allow the confirmation of the seen couraging results.

show abstract

Evaluating Cutimed^®> Sorbact^®>: using a case study approach

Cited by 5 publications

References 7 publications

Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review

Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review

Alumina Ceramic Textiles as Novel Bacteria‐Capturing Wound Dressings

Enhancing Skin Cicatrization with Natural Sources – The Role of Polyunsaturated Fatty Acids (PUFAs) and Beeswax

Contact Info

Product

Resources

About

Evaluating Cutimed®> Sorbact®>: using a case study approach

Cited by 5 publications

References 7 publications

Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review

Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review

Alumina Ceramic Textiles as Novel Bacteria‐Capturing Wound Dressings

Enhancing Skin Cicatrization with Natural Sources – The Role of Polyunsaturated Fatty Acids (PUFAs) and Beeswax

Contact Info

Product

Resources

About

Evaluating Cutimed^®> Sorbact^®>: using a case study approach